Exploring the clinical value of innovations in lipid managementJune 4, 2010
Master class: Exploring the clinical value of innovations in lipid management
Held in Barcelona, Spain in June, 2010
Recent insights from epidemiology: How important are lipids and apolipoproteins for prediction of future CV events?
Jane Armitage, MD, Clinical Trials Service Unit, University of Oxford, United Kingdom
Insights from clinical trials: The unassailable case for LDL-c lowering
Kausik Ray, MD University of Cambridge, United Kingdom
Residual risk: Does it exist and how do we target it?
Richard Hobbs, MD, University of Birmingham, United Kingdom
A patient with Familial Hypercholesterolemia: How to get these difficult patients to goal?
Emilio Ros, MD, Endocrinology & Nutrition Service , Hospital Clínico, Barcelona, Spain
The diabetic patient with low HDL and high Triglycerides: What are the therapeutic options?
John Betteridge, MD, University College London, United Kingdom
A patient with a heart attack early in life:The case for very low LDL-c levels
John Deanfield, MD, University College London, United Kingdom
A patient with severe hypertriglyceridemia and acute pancreatitis: What should we do?
Erik Stroes, MD, Academic Medical Centre, Amsterdam, The Netherlands
Novel therapies for the prevention of atherosclerotic vascular disease
John Kastelein, MD, Academic Medical Centre, Amsterdam , The Netherlands
Kausik Ray, MD
University of Cambridge
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.